Biochemical Aspects of Chronic Granulocytic Leukaemia
Author Information
Author(s): K. R. Harrap, D. E. M. Speed
Primary Institution: Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital
Hypothesis
Are there detectable abnormalities in the levels of protein-free sulphydryl compounds in the blood of patients undergoing treatment with busulphan?
Conclusion
The study found that a soluble disulphide occurs in the blood of patients with chronic granulocytic leukaemia undergoing treatment, but is absent in those in remission.
Supporting Evidence
- Patients with chronic granulocytic leukaemia showed a presence of soluble disulphide in the leucocyte fraction.
- Untreated patients had similar total protein-free sulphydryl levels compared to healthy controls.
- Patients undergoing treatment with busulphan had significantly lower total SH levels in leucocytes.
Takeaway
Doctors studied blood from leukaemia patients to see if certain chemicals were different compared to healthy people, and they found some changes when patients were treated.
Methodology
Blood samples were taken from patients and analyzed for levels of protein-free sulphydryl and disulphide compounds using various chemical procedures.
Limitations
The study did not prevent autoxidation of thiols in plasma, which may affect the results.
Participant Demographics
The study included 11 patients with chronic granulocytic leukaemia and 8 healthy volunteers.
Want to read the original?
Access the complete publication on the publisher's website